Effect of nonesterified fatty acids on the stability of prostacyclin activity.
The half-life of the platelet antiaggregatory activity of prostacyclin (PGI2) is prolonged when PGI2 is incubated in human plasma or in fatty-acid-free human albumin solutions. This "PGI2-protective" effect is diminished when fatty acids are added to the incubate, and the diminution is proportional to the concentration of the nonesterified fatty acids added. Unsaturated fatty acids were more potent in causing this reduction than saturated acids. It is possible that nonesterified fatty acids displace PGI2 from binding sites on the albumin molecule and that they may thus alter the biologic half-life of any circulating PGI2. This observation may partly account for the well-documented association between raised serum nonesterified fatty acid levels and thrombosis/platelet activation.
D002021:Buffers; D011464:Epoprostenol / Q000037:antagonists & inhibitors / Q000097:blood / Q000494:pharmacology*; D000431:Ethanol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology*; D012709:Serum Albumin
D002021:Buffers; D005230:Fatty Acids, Nonesterified; D011453:Prostaglandins; D012709:Serum Albumin; D000431:Ethanol; D011464:Epoprostenol